Induction of immune response against NY-ESO-1 by CHP-NY-ESO-1 vaccination and immune regulation in a melanoma patient Kazuhide TsujiToshitada HamadaKeiji Iwatsuki Original Article 01 March 2008 Pages: 1429 - 1437
IL-21 induces in vivo immune activation of NK cells and CD8+ T cells in patients with metastatic melanoma and renal cell carcinoma Klaus Stensgaard FrederiksenDorthe LundsgaardKresten Skak Original Article Open access 20 February 2008 Pages: 1439 - 1449
Zoledronic acid modulates antitumoral responses of prostate cancer-tumor associated macrophages Panagiotis TsagozisFredrik ErikssonPavel Pisa Original Article 23 February 2008 Pages: 1451 - 1459
Gamma-IFN-inducible-lysosomal thiol reductase modulates acidic proteases and HLA class II antigen processing in melanoma Oliver G. GoldsteinLaela M. HajiaghamohseniAzizul Haque Original Article 15 March 2008 Pages: 1461 - 1470
Immune, endocrine, and behavioral precursors to breast cancer recurrence: a case-control analysis Lisa M. ThorntonBarbara L. AndersenWilliam E. Carson III Original Article 08 March 2008 Pages: 1471 - 1481
Generation of antigen-specific CTL responses using RGS1 mRNA transfected dendritic cells Frank GrünebachStefanie ErndtPeter Brossart Original Article 27 February 2008 Pages: 1483 - 1491
Lung cancer patients’ CD4+ T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cells Minu K. SrivastavaJacobus J. BoschSuzanne Ostrand-Rosenberg Original Article 06 March 2008 Pages: 1493 - 1504
Translating immunity into cancer therapy: new findings from the first conference of the European Society for Cancer Immunology and Immunotherapy, an ESMO-EIS held in Athens, 15–17 November 2007 Graham PawelecSonia Perez Meeting Report 01 March 2008 Pages: 1505 - 1509
The E75 HER2/neu peptide vaccine Elizabeth A. MittendorfJarrod P. HolmesGeorge E. Peoples Symposium Paper 07 June 2008 Pages: 1511 - 1521
Combined modality immunotherapy and chemotherapy: a new perspective Rupal RamakrishnanScott AntoniaDmitry I. Gabrilovich Symposium Paper 17 May 2008 Pages: 1523 - 1529
Spontaneous immune responses to sporadic tumors: tumor-promoting, tumor-protective or both? Karin E. de Visser Symposium Paper 15 March 2008 Pages: 1531 - 1539
NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapy Karl-Johan MalmbergYenan T. BrycesonHans-Gustaf Ljunggren Symposium Paper 04 March 2008 Pages: 1541 - 1552
Anti-angiogenesis: making the tumor vulnerable to the immune system Arjan W. Griffioen Symposium Paper Open access 26 April 2008 Pages: 1553 - 1558
Dendritic cell vaccination and immune monitoring E. H. J. G. AarntzenC. G. FigdorI. J. M. de Vries Symposium Paper Open access 10 July 2008 Pages: 1559 - 1568
Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines Tanja D. de GruijlAlfons J. M. van den EertweghRik J. Scheper Symposium Paper Open access 04 June 2008 Pages: 1569 - 1577
